Rexall Osteo Bi-Flex retail sales of $25 mil. in third quarter boosted by ad spend.
This article was originally published in The Tan Sheet
Executive Summary
REXALL SUNDOWN OSTEO BI-FLEX RETAIL SALES OF $25 MIL. IN THIRD QUARTER fiscal 1998 (ended May 31) keep the glucosamine- chondroitin joint/cartilage health product the "third best- selling nutritional supplement in the country" in terms of dollars, the company said. Osteo Bi-Flex has been a "tremendous success," Rexall Sundown said, "already becoming a national brand" with 70%-plus distribution at retail and mass market outlets. By comparison, Osteo Bi-Flex sales in the fiscal second quarter were $11 mil.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning